Advertisement

Cardiovascular Toxicology

, Volume 19, Issue 1, pp 82–89 | Cite as

Severe Cardiomyopathy Due to Arthroprosthetic Cobaltism: Report of Two Cases with Different Outcomes

  • Hyo-In ChoiEmail author
  • Jung Ae Hong
  • Min-Seok Kim
  • Sang Eun Lee
  • Sung-Ho Jung
  • Pil Whan Yoon
  • Joon Seon Song
  • Jae-Joong Kim
Article
  • 203 Downloads

Abstract

Cobalt-induced cardiomyopathy is a well-known but uncommon disease, and the physician must maintain a high index of suspicion in order to make a timely diagnosis. We report two patients with cobalt-induced cardiomyopathy. Both patients developed progressively worsening symptoms of cobalt toxicity following revision of a fractured ceramic-on-ceramic total hip replacement to a metal-on-polyethylene bearing. In both patients, echocardiography showed LV hypertrophy, biventricular systolic dysfunction, and a large amount of pericardial effusion. Due to decompensated heart failure, both patients were initially considered candidates for heart transplantation. One patient was diagnosed with cobalt-induced cardiomyopathy before transplantation. He received cobalt chelation therapy and revision surgery, which led to complete recovery of heart function. In the other patient, the diagnosis was not made until the time of heart transplantation. The gross examination of the explanted heart revealed typical features of cobalt cardiotoxicity, which was then diagnosed as cobalt-induced cardiomyopathy. These cases emphasise the importance of early diagnosis and prompt treatment of cobalt intoxication.

Keywords

Cobalt Cardiomyopathy Metallosis Heart failure Prognosis Transplantation 

References

  1. 1.
    Gilbert, C. J., et al. (2013). Hip pain and heart failure: The missing link. Canadian Journal of Cardiology, 29(5), 639e1–e2.CrossRefGoogle Scholar
  2. 2.
    Machado, C., Appelbe, A., & Wood, R. (2012). Arthroprosthetic cobaltism and cardiomyopathy. Heart, Lung and Circulation, 21(11), 759–760.CrossRefGoogle Scholar
  3. 3.
    van Lingen, C. P., et al. (2013). Clinical manifestations in ten patients with asymptomatic metal-on-metal hip arthroplasty with very high cobalt levels. Hip International, 23(5), 441–444.CrossRefGoogle Scholar
  4. 4.
    Oldenburg, M., Wegner, R., & Baur, X. (2009). Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. The Journal of Arthroplasty, 24(5), 825 e15–e20.CrossRefGoogle Scholar
  5. 5.
    Cheung, A. C., et al. (2016). Systemic cobalt toxicity from total hip arthroplasties: Review of a rare condition Part 1—History, mechanism, measurements, and pathophysiology. The Bone & Joint Journal, 98-b(1), 6–13.CrossRefGoogle Scholar
  6. 6.
    Gessner, B. D., et al. (2015). A systematic review of systemic cobaltism after wear or corrosion of chrome-cobalt hip implants. Journal of Patient Safety, 0, 1–8CrossRefGoogle Scholar
  7. 7.
    Tower, S. S. (2010). Arthroprosthetic cobaltism: Neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: A case report. The Journal of Bone and Joint Surgery, 92(17), 2847–2851.CrossRefGoogle Scholar
  8. 8.
    Catalani, S., et al. (2012). Neurotoxicity of cobalt. Human & Experimental Toxicology, 31(5), 421–437.CrossRefGoogle Scholar
  9. 9.
    Mosier, B. A., Maynard, L., Sotereanos, N. G., Sewecke, J. J. (2016). Progressive cardiomyopathy in a patient with elevated cobalt ion levels and bilateral metal-on-metal hip arthroplasties. The American Journal of Orthopedics, 45(3), E132–E135.Google Scholar
  10. 10.
    Zywiel, M. G., et al. (2013). Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. The Bone & Joint Journal, 95(1), 31–37.CrossRefGoogle Scholar
  11. 11.
    Allen, L. A., et al. (2014). Clinical problem-solving. Missing elements of the history. The New England Journal of Medicine, 370(6), 559–566.CrossRefGoogle Scholar
  12. 12.
    Samar, H. Y., et al. (2015). Novel use of cardiac magnetic resonance imaging for the diagnosis of cobalt cardiomyopathy. JACC Cardiovasc Imaging, 8(10), 1231–1232.CrossRefGoogle Scholar
  13. 13.
    Kempf, I., & Semlitsch, M. (1990). Massive wear of a steel ball head by ceramic fragments in the polyethylene acetabular cup after revision of a total hip prosthesis with fractured ceramic ball. Archives of Orthopaedic and Trauma Surgery, 109(5), 284–287.CrossRefGoogle Scholar
  14. 14.
    Morin, Y., Tetu, A., & Mercier, G. (1971). Cobalt cardiomyopathy: Clinical aspects. British Heart Journal, 33(p. Suppl), 175–178.CrossRefGoogle Scholar
  15. 15.
    Morin, Y., Tetu, A., & Mercier, G. (1969). Quebec beer-drinkers’ cardiomyopathy: Clinical and hemodynamic aspects. Annals of the New York Academy of Sciences, 156(1), 566–576.CrossRefGoogle Scholar
  16. 16.
    Alexander, C. S. (1972). Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. The American Journal of Medicine, 53(4), 395–417.CrossRefGoogle Scholar
  17. 17.
    Tilney, R., Burg, M. R., & Sammut, M. A., (2017). Cobalt cardiomyopathy secondary to hip arthroplasty: An increasingly prevalent problem. Case Reports in Cardiology, 2017, 5434571.CrossRefGoogle Scholar
  18. 18.
    Pandit, H., et al. (2008). Pseudotumours associated with metal-on-metal hip resurfacings. The Journal of Bone and Joint Surgery British, 90(7), 847–851.CrossRefGoogle Scholar
  19. 19.
    Polyzois, I., et al. (2012). Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. Journal of Applied Toxicology, 32(4), 255–269.CrossRefGoogle Scholar
  20. 20.
    Gill, H. S., et al. (2012). Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends in Molecular Medicine, 18(3), 145–155.CrossRefGoogle Scholar
  21. 21.
    Papageorgiou, I., et al. (2007). The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials, 28(19), 2946–2958.CrossRefGoogle Scholar
  22. 22.
    Tower, S. (2010). Arthroprosthetic cobaltism: Identification of the at-risk patient. Alaska Medicine, 52, 28–32.Google Scholar
  23. 23.
    Sotos, J. G., & Tower, S. S. (2013). Systemic disease after hip replacement: Aeromedical implications of arthroprosthetic cobaltism. Aviation, Space, and Environmental Medicine, 84(3), 242–245.CrossRefGoogle Scholar
  24. 24.
    Heggtveit, H. A., Grice, H. C., & Wiberg, G. S. (1970). Cobalt cardiomyopathy. Experimental basis for the human lesion. Pathologia et Microbiologia (Basel), 35(1), 110–113.Google Scholar
  25. 25.
    Dingle, J. T., et al. (1962). The biological action of cobalt and other metals. II. The mechanism of the respiratory inhibition produced by cobalt in mammalian tissues. Biochimica et Biophysica Acta, 65, 34–46.CrossRefGoogle Scholar
  26. 26.
    Rona, G., (1971). Experimental aspects of cobalt cardiomyopathy. British Heart Journal, 33(Suppl), 171–174.CrossRefGoogle Scholar
  27. 27.
    Harrow, J. A., Das, P. K., & Dhalla, N. S. (1978). Influence of some divalent cations on heart sarcolemmal bound enzymes and calcium binding. Biochemical Pharmacology, 27(22), 2605–2609.CrossRefGoogle Scholar
  28. 28.
    Barceloux, D. G. (1999). Cobalt. Journal of Toxicology: Clinical Toxicology, 37(2), 201–206.Google Scholar
  29. 29.
    Unverferth, D. V., et al. (1984). The evolution of beta-adrenergic dysfunction during the induction of canine cobalt cardiomyopathy. Cardiovascular Research, 18(1), 44–50.CrossRefGoogle Scholar
  30. 30.
    Seghizzi, P., et al. (1994). Cobalt myocardiopathy. A critical review of literature. Science of the Total Environment, 150(1–3), 105–109.CrossRefGoogle Scholar
  31. 31.
    Tabel, G. M., et al. (2006). Collagen fiber morphology determines echogenicity of myocardial scar: Implications for image interpretation. Echocardiography, 23(2), 103–107.CrossRefGoogle Scholar
  32. 32.
    Mohiuddin, S. M., et al. (1970). Experimental cobalt cardiomyopathy. American Heart Journal, 80(4), 532–543.CrossRefGoogle Scholar
  33. 33.
    Giampreti, A., Lonati, D., & Locatelli, C. A. (2014). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 30(4), 465.e13.CrossRefGoogle Scholar
  34. 34.
    Devlin, J. J., Schwartz, M., & Brent, J. (2013). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 29(11), 1533.e7.CrossRefGoogle Scholar
  35. 35.
    Smith, S. W. (2013). The role of chelation in the treatment of other metal poisonings. Journal of Medical Toxicology, 9, 355–369.CrossRefGoogle Scholar
  36. 36.
    Pazzaglia, U. E., et al. (2011). Cobalt, chromium and molybdenum ions kinetics in the human body: Data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Archives of Orthopaedic and Trauma Surgery, 131(9), 1299–1308.CrossRefGoogle Scholar
  37. 37.
    Repo, E., et al. (2011). Capture of Co(II) from its aqueous EDTA-chelate by DTPA-modified silica gel and chitosan. Journal of Hazardous Materials, 187(1–3), 122–132.CrossRefGoogle Scholar
  38. 38.
    Giampreti, A., et al. (2016). N-acetyl-cysteine as effective and safe chelating agent in metal-on-metal hip-implanted patients: Two cases. Case Reports in Orthopedics, 2016, 8682737.CrossRefGoogle Scholar
  39. 39.
    Asapoglu, N. K., Toprak, A. B.,M. S., Koseoglu, Y., & Bayrakdar, H. (2000). Synthesis and characterization of NiFe ~ 2O ~ 4 nano-octahedrons by EDTA-assisted hydro-thermal method. Turkish Journal of Chemistry, 30, 659–666.Google Scholar
  40. 40.
    Kwon, Y. M., et al. (2014). Risk stratification algorithm for management of patients with dual modular taper total hip arthroplasty: Consensus statement of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons and the Hip Society. The Journal of Arthroplasty, 29(11), 2060–2064.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Cardiology, Department of Internal Medicine, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulSouth Korea
  2. 2.Department of Thoracic and Cardiovascular Surgery, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulSouth Korea
  3. 3.Department of Orthopaedic Surgery, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulSouth Korea
  4. 4.Department of Pathology, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulSouth Korea

Personalised recommendations